Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Strata Critical Medical (SRTA) Gross Profit (2021 - 2025)

Strata Critical Medical (SRTA) has disclosed Gross Profit for 5 consecutive years, with $11.7 million as the latest value for Q4 2025.

  • Quarterly Gross Profit rose 132.75% to $11.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $93.9 million through Dec 2025, up 140.66% year-over-year, with the annual reading at $41.1 million for FY2025, 38.99% up from the prior year.
  • Gross Profit for Q4 2025 was $11.7 million at Strata Critical Medical, roughly flat from $11.6 million in the prior quarter.
  • The five-year high for Gross Profit was $68.8 million in Q3 2023, with the low at -$127.6 million in Q4 2023.
  • Average Gross Profit over 5 years is $12.0 million, with a median of $10.9 million recorded in 2024.
  • The sharpest move saw Gross Profit soared 1582.25% in 2022, then crashed 2663.92% in 2023.
  • Over 5 years, Gross Profit stood at $3.9 million in 2021, then grew by 26.24% to $5.0 million in 2022, then plummeted by 2663.92% to -$127.6 million in 2023, then surged by 103.93% to $5.0 million in 2024, then surged by 132.75% to $11.7 million in 2025.
  • According to Business Quant data, Gross Profit over the past three periods came in at $11.7 million, $11.6 million, and $17.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.